The field of cancer research is extremely expansive, with innovations taking place every single day. With the field being this vast, it becomes difficult for doctors from all over to be connected with each other to share the findings that the make and the innovations that come into place. The need for a newsletter that helps doctors to connect with each other and share their views and opinions and research was prominent, which is why Mikhail Blagosklonny tried to fill this void with the publication of Oncotarget. Oncotarget functions as a peer to peer review newsletter, which is open to doctors and those who are interested in the field of oncology from around the world. Doctors who are making advances in the area of oncology are encouraged to send in their articles discussing their discoveries and thoughts on the latest innovations in the field.
The newsletter has managed to bridge the gap between doctors and oncologists from all over the world, offering them a glance into how doctors treat their patients in different countries. The newsletter takes pride in being entirely global, with contributors giving different perspectives on how patients who are diagnosed with cancer are being treated in their countries.The newsletter was founded by Mikhail Blagosklonny in 2010. Since its first publication, the readership and contributors to the newsletter have grown significantly. When a doctor or researcher sends in their articles to be published through Oncotarget, they are reviewed by Mikhail Blagosklonny and his team of trusted associates who have a good amount of experience in the field. The articles are chosen based on their originality, and whether or not they can be a significant contribution to the field.
The articles go way beyond the conventional topics that oncological research journals cover so that they can truly expand on the subject in the best way to treat cancer. By doing this, the newsletter puts out only that content that is one of a kind and talks about the latest happenings in the field.Oncotarget does not have a restriction and can be viewed by literally anyone who is interested in the field. The newsletter is published weekly, with new topics and new innovations being featured every week. The ultimate aim of the publication is to facilitate the spread of knowledge among doctors so that the entire oncological community can grow and develop as one cohesive unit for the betterment of society and the people.